We have built our pipeline of rare disease products largely based on collaborations and licenses with both academic and corporate partners. We continue to seek new opportunities at all stages of development. 

Parties developing products or technologies for rare genetic diseases that are interested in collaborating with Ultragenyx can contact our business development team.

Send any inquiries by email to: